Laboratory Reference Grade Compounds

SR9009 / Stenabolic (20mg Research Vial)

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱2,400.00
Out of stock
Net Content20MG
InclusionVial Only
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (20MG)
Diluent:mL
Concentration20.00 mg/mLin 1.0mL BAC
Standard Dose5.0 mg – 20.0 mg Daily Analytical WindowSyringe: 50.0 units (0.50 mL)
Scale (1 Unit)200 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
SR9009 / Stenabolic (20mg Research Vial)20MG · Vial Only
₱2,400.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: SR9009 (Stenabolic) is a synthetic small-molecule agonist of Rev-ErbAα and Rev-ErbAβ, nuclear hormone receptors that orchestrate the mammalian circadian clock and metabolic homeostasis.

How it works: By binding Rev-Erb receptors, SR9009 upregulates the transcription of fatty acid and glucose oxidation genes, increasing mitochondrial density in skeletal muscle and driving resting metabolic expenditure.

Why researchers study it: Famous in preclinical exercise physiology for boosting running capacity, aerobic endurance, and energy expenditure in murine models without physical training.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryMetabolic Signaling & Incretins
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number1379686-30-2
PubChem CID56640146↗
Molecular Weight437.94 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options20MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaC20H24ClN3O4S